Retrospective study shows treatment improves lung function in cystic fibrosis patients, suggesting real-world efficacy of ELX/TEZ/IVA.
Substantial improvements in lung function and reductions in HCRU were observed after treatment with ELX/TEZ/IVA in the Verona CF Center. Results contribute to the growing evidence of country-specific real-world data on the positive impact of ELX/TEZ/IVA.
No takes yet. Share an insight, caveat, or question.
Cipolli et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: